Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC VX-765 273404-37-8 10mM (in 1mL DMSO)
Supplier: Apexbio Technology LLC A82385.1
VX-765 (CAS 273404-37-8) is an orally bioavailable prodrug of VRT-043198 a selective inhibitor targeting caspase-1 (also known as IL-1 converting enzyme ICE) Caspase-1 plays a pivotal role in processing pro-inflammatory cytokines specifically converting inactive precursors of IL-1 and IL-18 into bioactive forms VX-765 downstream metabolite VRT-043198 selectively reduces the secretion of IL-1 and IL-18 in stimulated human peripheral blood mononuclear cells without affecting release of other cytokines such as IL-6 or TNF- Preclinical studies demonstrate VX-765 activity in mouse models of arthritis dermatitis and HIV-associated CD4 T-cell death indicating utility in inflammatory and immunological research
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?